Ciprofloxacin dispersion for inhalation

DRUG2 trials

Sponsors

Aradigm Corporation

Conditions

Non Cystic Fibrosis Bronchiectasis

Phase 3

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

CompletedNCT01515007

Aradigm CorporationNon Cystic Fibrosis Bronchiectasis

Start: 2014-03-31End: 2016-10-31Updated: 2021-03-26

Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4)

CompletedNCT02104245

Aradigm CorporationNon Cystic Fibrosis Bronchiectasis

Start: 2014-05-28End: 2016-10-31Updated: 2021-03-26

Related Papers

Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials.

2019-01-15149 citations

Open-label extension (OLE) of ORBIT-3 and ORBIT-4 trials of ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB)

2018-09-153 citations